Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 77
Filter
1.
mSphere ; 5(4)2020 07 29.
Article in English | MEDLINE | ID: mdl-32727857

ABSTRACT

The gastrointestinal microbiome plays an important role in limiting susceptibility to infection with Clostridioides difficile To better understand the ecology of bacteria important for C. difficile colonization resistance, we developed an experimental platform to simplify complex communities of fecal bacteria through dilution and rapidly screen for their ability to resist C. difficile colonization after challenge, as measured by >100-fold reduction in levels of C. difficile in challenged communities. We screened 76 simplified communities diluted from cultures of six fecal donors and identified 24 simplified communities that inhibited C. difficile colonization in vitro Sequencing revealed that simplified communities were composed of 19 to 67 operational taxonomic units (OTUs) and could be partitioned into four distinct community types. One simplified community could be further simplified from 56 to 28 OTUs through dilution and retain the ability to inhibit C. difficile We tested the efficacy of seven simplified communities in a humanized microbiota mouse model. We found that four communities were able to significantly reduce the severity of the initial C. difficile infection and limit susceptibility to disease relapse. Analysis of fecal microbiomes from treated mice demonstrated that simplified communities accelerated recovery of indigenous bacteria and led to stable engraftment of 19 to 22 OTUs from simplified communities. Overall, the insights gained through the identification and characterization of these simplified communities increase our understanding of the microbial dynamics of C. difficile infection and recovery.IMPORTANCEClostridioides difficile is the leading cause of antibiotic-associated diarrhea and a significant health care burden. Fecal microbiota transplantation is highly effective at treating recurrent C. difficile disease; however, uncertainties about the undefined composition of fecal material and potential long-term unintended health consequences remain. These concerns have motivated studies to identify new communities of microbes with a simpler composition that will be effective at treating disease. This work describes a platform for rapidly identifying and screening new simplified communities for efficacy in treating C. difficile infection. Four new simplified communities of microbes with potential for development of new therapies to treat C. difficile disease are identified. While this platform was developed and validated to model infection with C. difficile, the underlying principles described in the paper could be easily modified to develop therapeutics to treat other gastrointestinal diseases.


Subject(s)
Clostridioides difficile/classification , Clostridioides difficile/physiology , Feces/microbiology , Gastrointestinal Microbiome , Microbiological Techniques/methods , Adult , Animals , Fecal Microbiota Transplantation , Female , Humans , Male , Mice , Middle Aged
2.
Arch Cardiol Mex ; 90(Supl): 100-110, 2020.
Article in English | MEDLINE | ID: mdl-32523138

ABSTRACT

The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic. Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation. The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of COVID-19.


Se presentan las recomendaciones en las cuales la Sociedad Mexicana de Cardiología (SMC) en conjunto con la Asociación Nacional de Cardiólogos de México (ANCAM), así como diferentes asociaciones médicas mexicanas vinculadas con la cardiología, después de una revisión y análisis exhaustivo y consensuado sobre los tópicos relacionados con las enfermedades cardiovasculares en la pandemia de COVID-19, se analizan posturas científicas y se dan recomendaciones responsables sobre medidas generales a los pacientes, con cuidados personales, alimentación saludable, actividad física regular, acciones en caso de paro cardiorrespiratorio, la protección del paciente y del personal de salud así como las indicaciones precisas en el uso de la imagen cardiovascular no invasiva, la prescripción de medicamentos, cuidados en tópicos específicos como en la hipertensión arterial sistémica, insuficiencia cardiaca, arritmias y síndromes coronarios agudos, además de hacer énfasis en los procedimientos de electrofisiología, intervencionismo, cirugía cardiaca y en la rehabilitación cardiaca. El interés principal es brindar a la comunidad médica una orientación general sobre el quehacer en la práctica cotidiana y pacientes con enfermedades cardiovasculares en el escenario esta crisis epidemiológica sin precedentes de COVID-19.


Subject(s)
Cardiology , Cardiovascular Diseases/therapy , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , COVID-19 , Cardiac Rehabilitation/methods , Cardiac Surgical Procedures/methods , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/virology , Humans , Mexico , Pandemics , Societies, Medical
3.
Arch Cardiol Mex ; 90(Supl): 41-44, 2020.
Article in English | MEDLINE | ID: mdl-32523146

ABSTRACT

COVID-19 is an acute respiratory syndrome caused by coronavirus-2 (SARS COV2). The different cardiac imaging methods have issued specific recommendations for the different imaging methods in this pandemic, so it is essential to emphasize the recommendations for carrying out these studies.


El COVID-19 es un síndrome respiratorio agudo ocasionado por el coronavirus-2 (SARS COV2). Los diferentes métodos de imagen cardiaca han dictado recomendaciones específicas de los diferentes métodos de imagen en esta pandemia, por lo que es indispensable recalcar las recomendaciones para la realización de estos estudios.


Subject(s)
Cardiac Imaging Techniques/methods , Coronavirus Infections/epidemiology , Occupational Exposure/prevention & control , Pneumonia, Viral/epidemiology , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/transmission , Humans , Pandemics , Personal Protective Equipment , Pneumonia, Viral/transmission , SARS-CoV-2
4.
Arch. cardiol. Méx ; 90(supl.1): 41-44, may. 2020. tab
Article in Spanish | LILACS | ID: biblio-1152842

ABSTRACT

Resumen El COVID-19 es un síndrome respiratorio agudo ocasionado por el coronavirus-2 (SARS COV2). Los diferentes métodos de imagen cardiaca han dictado recomendaciones específicas de los diferentes métodos de imagen en esta pandemia, por lo que es indispensable recalcar las recomendaciones para la realización de estos estudios.


Abstract COVID-19 is an acute respiratory syndrome caused by coronavirus-2 (SARS COV2). The different cardiac imaging methods have issued specific recommendations for the different imaging methods in this pandemic, so it is essential to emphasize the recommendations for carrying out these studies.


Subject(s)
Humans , Pneumonia, Viral/epidemiology , Occupational Exposure/prevention & control , Coronavirus Infections/epidemiology , Cardiac Imaging Techniques/methods , Pneumonia, Viral/transmission , Coronavirus Infections/transmission , Pandemics , Personal Protective Equipment , Betacoronavirus/isolation & purification , SARS-CoV-2 , COVID-19
5.
Alcocer-Gamba, Marco A; Gutiérrez-Fajardo, Pedro; Cabrera-Rayo, Alfredo; Sosa-Caballero, Alejandro; Piña-Reyna, Yigal; Merino-Rajme, José A; Heredia-Delgado, José A; Cruz-Alvarado, Jaime E; Galindo-Uribe, Jaime; Rogel-Martínez, Ulises; González-Hermosillo, Jesús A; Ávila-Vanzzini, Nydia; Sánchez-Carranza, Jesús A; Jímenez-Orozco, Jorge H; Sahagún-Sánchez, Guillermo; Fanghänel-Salmón, Guillermo; Albores-Figueroa, Rosenberg; Carrillo-Esper, Raúl; Reyes-Terán, Gustavo; Cossio-Aranda, Jorge E; Borrayo-Sánchez, Gabriela; Ríos, Manuel Odín de los; Berni-Betancourt, Ana C; Cortés-Lawrenz, Jorge; Leiva-Pons, José L; Ortiz-Fernández, Patricio H; López-Cuellar, Julio; Araiza-Garaygordobil, Diego; Madrid-Miller, Alejandra; Saturno-Chiu, Guillermo; Beltrán-Nevárez, Octavio; Enciso-Muñoz, José M; García-Rincón, Andrés; Pérez-Soriano, Patricia; Herrera-Gomar, Magali; Lozoya del Rosal, José J; Fajardo-Juárez, Armando I; Olmos-Temois, Sergio G; Rodríguez-Reyes, Humberto; Ortiz-Galván, Fernando; Márquez-Murillo, Manlio F; Celaya-Cota, Manuel de J; Cigarroa-López, José A; Magaña-Serrano, José A; Álvarez-Sangabriel, Amada; Ruíz-Ruíz, Vicente; Chávez-Mendoza, Adolfo; Méndez-Ortíz, Arturo; León-González, Salvador; Guízar-Sánchez, Carlos; Izaguirre-Ávila, Raúl; Grimaldo-Gómez, Flavio A; Preciado-Anaya, Andrés; Ruiz-Gastélum, Edith; Fernández-Barros, Carlos L; Gordillo, Antonio; Alonso-Sánchez, Jesús; Cerón-Enríquez, Norma; Núñez-Urquiza, Juan P; Silva-Torres, Jesús; Pacheco-Beltrán, Nancy; García-Saldivia, Marianna A; Pérez-Gámez, Juan C; Lezama-Urtecho, Carlos; López-Uribe, Carlos; López-Mora, Gerardo E; Rivera-Reyes, Romina.
Arch. cardiol. Méx ; 90(supl.1): 100-110, may. 2020.
Article in Spanish | LILACS | ID: biblio-1152852

ABSTRACT

Resumen Se presentan las recomendaciones en las cuales la Sociedad Mexicana de Cardiología (SMC) en conjunto con la Asociación Nacional de Cardiólogos de México (ANCAM), así como diferentes asociaciones médicas mexicanas vinculadas con la cardiología, después de una revisión y análisis exhaustivo y consensuado sobre los tópicos relacionados con las enfermedades cardiovasculares en la pandemia de COVID-19, se analizan posturas científicas y se dan recomendaciones responsables sobre medidas generales a los pacientes, con cuidados personales, alimentación saludable, actividad física regular, acciones en caso de paro cardiorrespiratorio, la protección del paciente y del personal de salud así como las indicaciones precisas en el uso de la imagen cardiovascular no invasiva, la prescripción de medicamentos, cuidados en tópicos específicos como en la hipertensión arterial sistémica, insuficiencia cardiaca, arritmias y síndromes coronarios agudos, además de hacer énfasis en los procedimientos de electrofisiología, intervencionismo, cirugía cardiaca y en la rehabilitación cardiaca. El interés principal es brindar a la comunidad médica una orientación general sobre el quehacer en la práctica cotidiana y pacientes con enfermedades cardiovasculares en el escenario esta crisis epidemiológica sin precedentes de COVID-19.


Abstract The recommendations in which the Mexican Society of Cardiology (SMC) in conjunction with the National Association of Cardiologists of Mexico (ANCAM) as well as different Mexican medical associations linked to cardiology are presented, after a comprehensive and consensual review and analysis of the topics related to cardiovascular diseases in the COVID-19 pandemic. Scientific positions are analyzed and responsible recommendations on general measures are given to patients, with personal care, healthy eating, regular physical activity, actions in case of cardio-respiratory arrest, protection of the patient and health personnel as well as precise indications in the use of non-invasive cardiovascular imaging, prescription of medications, care in specific topics such as systemic arterial hypertension, heart failure, arrhythmias and acute coronary syndromes, in addition to emphasizing electrophysiology, interventionism, cardiac surgery and in cardiac rehabilitation. The main interest is to provide the medical community with a general orientation on what to do in daily practice and patients with cardiovascular diseases in the setting of this unprecedented epidemiological crisis of COVID-19.


Subject(s)
Humans , Pneumonia, Viral/epidemiology , Cardiology , Cardiovascular Diseases/therapy , Coronavirus Infections/epidemiology , Societies, Medical , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/virology , Pandemics , Cardiac Rehabilitation/methods , COVID-19 , Cardiac Surgical Procedures/methods , Mexico
6.
Cell Mol Neurobiol ; 38(1): 85-108, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28884431

ABSTRACT

Angiotensin II, through AT1 receptor stimulation, mediates multiple cardiovascular, metabolic, and behavioral functions including the response to stressors. Conversely, the function of Angiotensin II AT2 receptors has not been totally clarified. In adult rodents, AT2 receptor distribution is very limited but it is particularly high in the adrenal medulla. Recent results strongly indicate that AT2 receptors contribute to the regulation of the response to stress stimuli. This occurs in association with AT1 receptors, both receptor types reciprocally influencing their expression and therefore their function. AT2 receptors appear to influence the response to many types of stressors and in all components of the hypothalamic-pituitary-adrenal axis. The molecular mechanisms involved in AT2 receptor activation, the complex interactions with AT1 receptors, and additional factors participating in the control of AT2 receptor regulation and activity in response to stressors are only partially understood. Further research is necessary to close this knowledge gap and to clarify whether AT2 receptor activation may carry the potential of a major translational advance.


Subject(s)
Adrenal Glands/metabolism , Hypothalamo-Hypophyseal System/metabolism , Pituitary-Adrenal System/metabolism , Receptor, Angiotensin, Type 2/metabolism , Stress, Psychological/metabolism , Adrenal Glands/drug effects , Angiotensin Receptor Antagonists/pharmacology , Animals , Humans , Hypothalamo-Hypophyseal System/drug effects , Pituitary-Adrenal System/drug effects , Stress, Psychological/psychology
7.
Pharmacogenomics J ; 16(1): 3-9, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25732908

ABSTRACT

Non-synonymous GRK4 variants, R65L, A142V and A486V, are associated with essential hypertension in diverse populations. This study replicated the association of GRK4 variants, including GRK4(142V), with human essential hypertension in a Japanese population (n=588; hypertensive, n=486 normotensive controls) and determined whether the presence of GRK4 variants predicted the blood pressure (BP) response to angiotensin receptor blockers (ARBs) in patients with essential hypertension. We analyzed 829 patients and compared the response to ARBs between individuals with no GRK4 variants (n=136) and those with variants at one or any of the three loci (n=693). Carriers of hGRK4(142V) had a greater decrease in systolic BP in response to ARBs than non-carrier hypertensive patients. By contrast, those with variants only at GRK4(486V) were less likely to achieve the BP goal in response to an ARB than those with no variants. These studies showed for the first time the association between GRK4(142V) and a larger decrease in BP with ARBs in hypertensive patients.


Subject(s)
Angiotensin Receptor Antagonists/therapeutic use , Blood Pressure/drug effects , Hypertension/genetics , Receptors, G-Protein-Coupled/genetics , Aged , Aged, 80 and over , Asian People , Case-Control Studies , Female , Genetic Association Studies , Genetic Loci , Genetic Markers , Haplotypes , Humans , Hypertension/drug therapy , Hypertension/physiopathology , Male , Middle Aged , Polymorphism, Single Nucleotide
8.
Molecules ; 20(4): 5440-55, 2015 Mar 27.
Article in English | MEDLINE | ID: mdl-25826785

ABSTRACT

Phenyleneimine oligomers 4,4'-(((1E,1'E)-(((1E,1'E)-(1,4-phenylenebis-(azanylylidene))bis(methanylylidene))bis(2,5-bis(octyloxy)-4,1-phenylene))bis(methanylyl-idene))-bis(azanylylidene))dianiline (OIC1MS) and 7,7'-(((1E,1'E)-(((1E,1'E)-((9H-fluorene-2,7-diyl)bis(azanylylidene))bis(methanylylidene))bis(2,5-bis(octyloxy)-4,1phenylene))bis- (methanylylidene))bis(azanylylidene))bis(9H-fluoren-2-amine) (OIC2MS) were prepared by means of conventional and mechanochemical synthesis and characterized by FT-IR, 1H- and 13C-NMR techniques. The optical properties of the compounds were studied in solution by using UV-visible spectroscopy, and the optical effects were analyzed as a function of solvent. The results show that OIC2MS exhibits interesting photochromic properties. Furthermore, the structural and electronic properties of the compounds were analyzed by TD-DFT. It was found that the mechanosynthesis is an efficient method for the synthesis of both tetraimines.


Subject(s)
Aniline Compounds/chemical synthesis , Photochemical Processes , Aniline Compounds/chemistry , Carbon-13 Magnetic Resonance Spectroscopy , Models, Molecular , Molecular Structure , Proton Magnetic Resonance Spectroscopy , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman
9.
Int J Pept ; 2013: 328140, 2013.
Article in English | MEDLINE | ID: mdl-23878547

ABSTRACT

Soluble amyloid beta peptide (A ß ) is responsible for the early cognitive dysfunction observed in Alzheimer's disease. Both cholinergically and glutamatergically induced hippocampal theta rhythms are related to learning and memory, spatial navigation, and spatial memory. However, these two types of theta rhythms are not identical; they are associated with different behaviors and can be differentially modulated by diverse experimental conditions. Therefore, in this study, we aimed to investigate whether or not application of soluble A ß alters the two types of theta frequency oscillatory network activity generated in rat hippocampal slices by application of the cholinergic and glutamatergic agonists carbachol or DHPG, respectively. Due to previous evidence that oscillatory activity can be differentially affected by different A ß peptides, we also compared Aß 25-35 and Aß 1-42 for their effects on theta rhythms in vitro at similar concentrations (0.5 to 1.0 µ M). We found that Aß 25-35 reduces, with less potency than Aß 1-42, carbachol-induced population theta oscillatory activity. In contrast, DHPG-induced oscillatory activity was not affected by a high concentration of Aß 25-35 but was reduced by Aß 1-42. Our results support the idea that different amyloid peptides might alter specific cellular mechanisms related to the generation of specific neuronal network activities, instead of exerting a generalized inhibitory effect on neuronal network function.

10.
Nat Prod Commun ; 6(9): 1393-6, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21941922

ABSTRACT

Leaves extracts and essential oil of Nectandra angustifolia were explored for the first time for neutralization of Bothrops neuwiedi diporus snake venom. The ethanol extract was the most active and inhibited both venom activities (hemolytic and coagulant), while the oil was only active on the coagulant activity. These observations confirmed that certain medicinal plants from Corrientes and Chaco Provinces possess significant snake venom neutralizing capacity and need further examination for their active constituents. Analysis by GC and GC-MS of the essential oil and the enantiomeric excess found for alpha-pinene, beta-pinene and limonene allowed a better characterization of this species.


Subject(s)
Bothrops/physiology , Crotalid Venoms/toxicity , Hemolysis/drug effects , Lauraceae/chemistry , Plant Extracts/pharmacology , Animals , Anticoagulants/pharmacology , Blood Coagulation , Plant Extracts/chemistry
11.
Stress ; 11(6): 457-66, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18609298

ABSTRACT

Spontaneously hypertensive rats, a stress-sensitive strain, were pretreated orally for 14 days with the AT(1) receptor antagonist candesartan before submission to 2 h of cold-restraint stress. In non-treated rats, stress decreased AT(1) receptor binding in the median eminence and basolateral amygdala, increased AT(2) receptor binding in the medial subnucleus of the inferior olive, decreased AT(2) binding in the ventrolateral thalamic nucleus and increased tyrosine hydroxylase mRNA level in the locus coeruleus. In non-stressed rats, AT(1) receptor blockade reduced AT(1) receptor binding in all areas studied and enhanced AT(2) receptor binding in the medial subnucleus of the inferior olive. Candesartan pretreatment produced a similar decrease in brain AT(1) binding after stress, and prevented the stress-induced AT(2) receptor binding decrease in the ventrolateral thalamic nucleus. In the locus coeruleus and adrenal medulla, AT(1) blockade abolished the stress-induced increase in tyrosine hydroxylase mRNA level. Our results demonstrate that oral administration of candesartan effectively blocked brain AT(1) receptors, selectively increased central AT(2) receptor expression and prevented the stress-induced central stimulation of tyrosine hydroxylase transcription. The present results support a role of brain AT(1) and AT(2) receptors in the regulation of the stress response, and the hypothesis that AT(1) receptor antagonists may be considered as potential therapeutic compounds in stress related disorders in addition to their anti-hypertensive properties.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/pharmacology , Benzimidazoles/pharmacology , Biphenyl Compounds/pharmacology , Brain/drug effects , Brain/metabolism , Locus Coeruleus/enzymology , Receptor, Angiotensin, Type 1/drug effects , Receptor, Angiotensin, Type 2/biosynthesis , Restraint, Physical/physiology , Stress, Physiological/physiology , Tetrazoles/pharmacology , Tyrosine 3-Monooxygenase/biosynthesis , Animals , Cold Temperature , Gene Expression/drug effects , Male , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR
12.
Ann N Y Acad Sci ; 1018: 76-84, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15240355

ABSTRACT

The presence of a brain Angiotensin II (Ang II) system, separated from and physiologically integrated with the peripheral, circulating renin-angiotensin system, is firmly established. Ang II is made in the brain and activates specific brain AT(1) receptors to regulate thirst and fluid metabolism. Some AT(1) receptors are located outside the blood-brain barrier and are sensitive to brain and circulating Ang II. Other AT(1) receptors, located inside the blood-brain barrier, respond to stimulation by Ang II of brain origin. AT(1) receptors in the subfornical organ, the hypothalamic paraventricular nucleus (PVN), and the median eminence are involved in the regulation of the stress response. In particular, AT(1) receptors in the PVN are under glucocorticoid control and regulate corticotrophin-releasing hormone (CRH) formation and release. In the PVN, restraint elicits a fast increase in AT(1) receptor mRNA expression. The expression of paraventricular AT(1) receptors is increased during repeated restraint and after 24 h of isolation stress, and their stimulation is essential for the hypothalamic-pituitary-adrenal axis activation, the hallmark of the stress response. Peripheral administration of an AT(1) receptor antagonist blocks peripheral and brain AT(1) receptors, prevents the sympathoadrenal and hormonal response to isolation stress, and prevents the gastric stress ulcers that are a characteristic consequence of cold-restraint stress. This evidence indicates that pharmacologic inhibition of the peripheral and brain Ang II system by AT(1) receptor blockade has a place in the prevention and treatment of stress-related disorders.


Subject(s)
Angiotensin II/physiology , Brain/physiopathology , Stress, Physiological/physiopathology , Angiotensin II/metabolism , Animals , Hypothalamus/metabolism , Hypothalamus/physiopathology , RNA, Messenger/genetics , Receptors, Angiotensin/genetics , Receptors, Angiotensin/metabolism , Renin-Angiotensin System
13.
Ann N Y Acad Sci ; 1018: 302-9, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15240382

ABSTRACT

The sympathoadrenal response to stress includes a profound increase in adrenomedullary catecholamine synthesis driven by stimulation of tyrosine hydroxylase (TH) transcription. We studied the role of Angiotensin II type 1 and 2 (AT(1) and AT(2)) receptors during isolation stress, and under basal conditions. Pretreatment of rats with the AT(1) receptor antagonist candesartan for 14 days prior to isolation completely prevented the stress-induced stimulation of catecholamine synthesis, decreasing tyrosine hydroxylase transcription by preventing the expression of the transcriptional factor, Fos-related antigen 2 (Fra-2). In addition, AT(1) receptor antagonism prevented the stress-induced increase in adrenomedullary AT(2) receptor binding and protein. Treatment of non-stressed, grouped animals under basal conditions with the AT(1) receptor or with PD 123319, an AT(2) receptor antagonist, decreased the adrenomedullary norepinephrine (NE) content and TH transcription. While AT(1) receptor antagonism decreased the levels of Fra-2 and the phosphorylated forms of cAMP responsive element binding protein (pCREB) and EKR2 (p-ERK2, phosphor-p42 MAP kinase), the AT(2) antagonist decreased Fra-2 with no change in the phosphorylation of CREB or EKR2. Our results demonstrate that both adrenomedullary AT(1) and AT(2) receptor types maintain and promote the adrenomedullary catecholamine synthesis and the transcriptional regulation of TH. Instead of opposing effects, however, our results indicate a complex synergistic regulation between the AT(1) and AT(2) receptor types.


Subject(s)
Adrenal Medulla/metabolism , Angiotensin II/metabolism , Catecholamines/biosynthesis , Gene Expression Regulation, Enzymologic , Receptors, Angiotensin/metabolism , Stress, Physiological/metabolism , Tyrosine 3-Monooxygenase/genetics , Angiotensin II/physiology , Animals , Male , Phosphorylation , RNA, Messenger/genetics , Rats , Rats, Wistar , Receptors, Angiotensin/classification , Stress, Physiological/physiopathology
14.
Ann N Y Acad Sci ; 1018: 351-5, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15240390

ABSTRACT

Cold-restraint stress reduces gastric blood flow and produces acute gastric ulcers. We studied the role of Angiotensin II (Ang II) on gastric blood flow and gastric ulceration during stress. Spontaneously hypertensive rats, a stress-sensitive strain, were pretreated for 14 days with the AT(1) receptor antagonist candesartan before cold-restraint stress. AT(1) blockade increased gastric blood flow 40% to 50%; prevented gastric ulcer formation by 70% to 80%; reduced the increase in adrenomedullary epinephrine and TH mRNA without preventing the stress-induced increase in adrenal corticosterone; decreased the stress-induced expression of tumor necrosis factor alpha (TNF-alpha) and adhesion protein ICAM-1 in arterial endothelium, and neutrophil infiltration in the gastric mucosa; and decreased PGE(2) content. AT(1) receptor blockers prevent stress-induced ulcerations by a combination of gastric blood flow protection, decreased sympathoadrenal activation, anti-inflammatory effects with reduction in TNF-alpha, and ICAM-1 expression, leading to reduced neutrophil infiltration while maintaining the protective glucocorticoid effects and PGE(2) release. Ang II has a crucial role, through stimulation of AT(1) receptors, in the production and progression of stress-induced gastric injury, and AT(1) receptor antagonists could be of therapeutic benefit.


Subject(s)
Angiotensin II/metabolism , Angiotensin Receptor Antagonists , Cold Temperature , Stomach Ulcer/prevention & control , Adrenal Medulla/enzymology , Adrenal Medulla/metabolism , Animals , Epinephrine/metabolism , Immunohistochemistry , Intercellular Adhesion Molecule-1/metabolism , Male , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred SHR , Receptors, Angiotensin/metabolism , Tumor Necrosis Factor-alpha/metabolism , Tyrosine 3-Monooxygenase/genetics , Tyrosine 3-Monooxygenase/metabolism
15.
Neuroendocrinology ; 78(4): 217-25, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14583654

ABSTRACT

High numbers of serotonin transporter (SERT) binding sites and high serotonin (5-HT) content are expressed in the adrenal medulla of wild-type (SERT+/+) mice. Acute restraint stress increases adrenomedullary 5-HT, norepinephrine (NE) and epinephrine (E) release, adrenomedullary tyrosine hydroxylase (TH) mRNA, and angiotensin II AT(2) receptor expression. There are no alterations in adrenal catecholamine content during restraint. In littermate SERT-/- mice, which do not express SERT binding sites, the basal adrenomedullary 5-HT content is significantly reduced and does not increase after stress. The stress-induced increase in plasma E is higher in SERT-/- than in SERT+/+ animals. In SERT-/- mice, the stress-induced increase in expression of TH mRNA does not occur, and as a consequence, adrenal E content decreases, and adrenal E and NE content are lower than that of SERT+/+ mice during restraint. In addition, instead of increased expression, stress induces a profound decrease in the number of adrenomedullary AT(2) receptors in SERT-/- mice. Our results indicate that SERT is necessary for the stress-induced increase in adrenomedullary catecholamine synthesis and AT(2) receptor expression. These data further indicate a close relationship between the adrenomedullary 5-HT and angiotensin II systems, and an important role of adrenomedullary AT(2) receptors in catecholamine synthesis and release during stress.


Subject(s)
Carrier Proteins/metabolism , Catecholamines/biosynthesis , Cocaine/analogs & derivatives , Membrane Glycoproteins/metabolism , Membrane Transport Proteins , Nerve Tissue Proteins , Receptors, Angiotensin/metabolism , Stress, Physiological/metabolism , Adrenal Glands/cytology , Adrenal Glands/metabolism , Animals , Binding Sites , Carrier Proteins/genetics , Catecholamines/blood , Chromatography, High Pressure Liquid , Cocaine/pharmacokinetics , In Situ Hybridization , Membrane Glycoproteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/metabolism , Radiopharmaceuticals/pharmacokinetics , Receptors, Angiotensin/genetics , Restraint, Physical/methods , Serotonin Plasma Membrane Transport Proteins , Stress, Physiological/physiopathology , Tyrosine 3-Monooxygenase/genetics , Tyrosine 3-Monooxygenase/metabolism
16.
Auton Autacoid Pharmacol ; 22(5-6): 261-8, 2002.
Article in English | MEDLINE | ID: mdl-12866806

ABSTRACT

1 There is good evidence that beta-blockers improve ventricular function, disease progression and survival in patients with left ventricular systolic dysfunction. The aim of this study was to determine the effects of atenolol therapy on the sympathetic nervous system at rest and after ergometric exercise, on left ventricular function and on baseline plasma atrial natriuretic factor (ANF) in ambulatory patients with chronic heart failure (CHF). 2 Twenty-two patients [left ventricular ejection fraction (LVEF) <36%; New York Heart Association II-III] were studied before atenolol treatment. Because of cardiac events (new Hospital admission or death) only 13 patients completed 1 year of treatment. Baseline noradrenaline (NE) concentrations were similar in patients and controls while ANF was higher in patients than in controls (328 +/- 35 pg ml(-1) vs. 37 +/- 3 pg ml(-1); P<0.01). 3 Patients with events showed higher NE (540 +/- 87 pg ml(-1) vs. 303 +/- 44 pg ml(-1); P<0.01) and ANF (460 +/- 70 pg ml(-1) vs. 291 +/- 44 pg ml(-1); P<0.03) at rest; and greater NE response to exercise (2.003 +/- 525 pg ml(-1) vs. 694 +/- 121 pg ml(-1); P<0.005). Atenolol treatment improved LVEF (19.5 +/- 1.9% vs. 33 +/- 3.9%; P<0.001), increased exercise tolerance (9 +/- 3.2 min vs. 17 +/- 4.8 min; P<0.001) and decreased plasma ANF (292 +/- 42 pg ml(-1) vs. 133 +/- 35 pg ml(-1); P<0.01). 4 Reduced basal dihydroxyphenylglycol (DHPG)/NE ratio (3.4 +/- 0.46 vs. 4.3 +/- 0.35; P<0.01) was observed in patients compared with healthy volunteers. Atenolol increased DHPG plasma levels (1.398 +/- 129 pg ml(-1) vs. 913 +/- 86 pg ml(-1); P<0.005) but the DHPG/NE ratio during exercise was not modified after treatment, suggesting that re-uptake of released NE is not changed by beta-blocker treatment. 5 In conclusion, the fact that atenolol treatment improves ventricular dysfunction and clinical status without changing plasma NE levels in CHF patients, suggests that plasma NE is a poor surrogate measurement for cardiac sympathetic activity in this pathology. In addition, decrease in plasma ANF produced by atenolol treatment may reflect the improvement of ventricular function.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Atenolol/therapeutic use , Atrial Natriuretic Factor/blood , Heart Failure/drug therapy , Heart/drug effects , Norepinephrine/blood , Ventricular Function, Left/drug effects , Blood Pressure/drug effects , Cardiomyopathy, Dilated/complications , Catecholamines/blood , Chronic Disease , Electrocardiography, Ambulatory , Ergometry , Exercise/physiology , Female , Heart Failure/blood , Heart Rate/drug effects , Humans , Male , Middle Aged , Sympathetic Nervous System/drug effects
17.
Regul Pept ; 102(1): 41-7, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11600209

ABSTRACT

Angiotensin II (Ang II) AT(2) receptor-gene disrupted mice have increased systemic blood pressure and response to exogenous Angiotensin II. To clarify the mechanism of these changes, we studied adrenal AT(1) receptor expression and mRNA by receptor autoradiography and in situ hybridization in female AT(2) receptor-gene disrupted mice (agtr 2-/-) and wild-type controls (agtr 2+/+). We found high expression of AT(1) receptor binding and mRNA in adrenal zona glomerulosa of female wild-type mice. AT(2) receptors and mRNA were highly expressed in adrenal medulla of wild-type mice, but were not detected in zona glomerulosa. There was no AT(2) receptor binding or mRNA in adrenal glands of AT(2) receptor-gene disrupted mice. In these animals, AT(1) receptor binding and mRNA were increased in adrenal zona glomerulosa and AT(1) receptor mRNA was increased in the adrenal medulla when compared with wild-type animals.The present data support the hypothesis of an interaction or cross talk between AT(2) and AT(1) receptors in adrenal gland. The significant increase in AT(1) receptor expression in the absence of AT(2) receptor transcription may be partially responsible for the increased blood pressure and for the enhanced response to exogenously administered Angiotensin II in this model.


Subject(s)
Adrenal Medulla/metabolism , Angiotensin II/pharmacology , Receptors, Angiotensin/genetics , Receptors, Angiotensin/metabolism , Zona Glomerulosa/metabolism , Animals , Autoradiography , Blood Pressure/drug effects , Female , Gene Expression Regulation , Genotype , Imidazoles/pharmacology , In Situ Hybridization , Losartan/pharmacology , Mice , Mice, Inbred Strains , Mice, Knockout , Mice, Mutant Strains , Pyridines/pharmacology , RNA, Messenger/metabolism , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Receptors, Angiotensin/deficiency , Transcription, Genetic , Vasoconstrictor Agents/pharmacology , Zona Glomerulosa/drug effects
18.
Endocrinology ; 142(9): 3880-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11517166

ABSTRACT

Angiotensin II, which stimulates AT(1) receptors, is a brain and peripheral stress hormone. We pretreated rats with the AT(1) receptor antagonist candesartan for 13 d via sc-implanted osmotic minipumps, followed by 24-h isolation in individual metabolic cages. We measured angiotensin II receptor-type binding and mRNAs and tyrosine hydroxylase mRNA by quantitative autoradiography and in situ hybridization, catecholamines by HPLC, and hormones by RIA. Isolation increased AT(1) receptor binding in hypothalamic paraventricular nucleus as well as anterior pituitary ACTH, and decreased posterior pituitary AVP. Isolation stress also increased AT(1) receptor binding and AT(1B) mRNA in zona glomerulosa and AT(2) binding in adrenal medulla, adrenal catecholamines, tyrosine hydroxylase mRNA, aldosterone, and corticosterone. Candesartan blocked AT(1) binding in paraventricular nucleus and adrenal gland; prevented the isolation-induced alterations in pituitary ACTH and AVP and in adrenal corticosterone, aldosterone, and catecholamines; abolished the increase in AT(2) binding in adrenal medulla; and substantially decreased urinary AVP, corticosterone, aldosterone, and catecholamines during isolation. Peripheral pretreatment with an AT(1) receptor antagonist blocks brain and peripheral AT(1) receptors and inhibits the hypothalamic-pituitary-adrenal response to stress, suggesting a physiological role for peripheral and brain AT(1) receptors during stress and a possible beneficial effect of AT(1) antagonism in stress-related disorders.


Subject(s)
Angiotensin Receptor Antagonists , Benzimidazoles/pharmacology , Hypothalamo-Hypophyseal System/physiopathology , Pituitary-Adrenal System/physiopathology , Social Isolation/psychology , Stress, Psychological/physiopathology , Tetrazoles/pharmacology , Adrenal Cortex Hormones/metabolism , Adrenal Glands/metabolism , Animals , Biphenyl Compounds , Brain/metabolism , Catecholamines/metabolism , Catecholamines/urine , Hormones/urine , Hypothalamo-Hypophyseal System/drug effects , Infusion Pumps , Injections, Subcutaneous , Male , Pituitary Hormones/metabolism , Pituitary-Adrenal System/drug effects , RNA, Messenger/metabolism , Rats , Rats, Wistar , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Receptors, Angiotensin/metabolism , Tyrosine 3-Monooxygenase/genetics
19.
Parkinsonism Relat Disord ; 8(1): 33-40, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11472878

ABSTRACT

Single intrastriatal microinjections of 25, 50 and 100nmol/microl of flunarizine in normal rats produced a dose-dependent turning behavior toward the injected side when they were challenged with apomorphine (1mg/kg, s.c). This effect was seen at 1, 3 and 7 days following administration of the high dose of flunarizine, but had subsided by 24h after administration of the intermediate dose; the low dose was ineffective. However, intrastriatal injection of the high dose of flunarizine resulted in a local lesion and thereafter this dose was not used. A similar dose-response relationship was determined for nifedipine, an L-type calcium channel antagonist. Injection of this antagonist did not result in apomorphine-elicited rotational behavior, reflecting its lack of antidopaminergic action. Intrastriatal injections of haloperidol (5microg/microl), an antagonist of dopamine D(2) receptors, or the sodium channel blocker lidocaine (40microg/microl), were given in order to compare their effects to those observed with flunarizine. Intracerebral injection of haloperidol produced ipsilateral turning in response to systemic administration of apomorphine given 60min after. The same response was obtained with the injection of apomorphine 10min after the injection of intracerebral lidocaine. This effect was no longer apparent 24h after the microinjection of haloperidol and 60min after the injection of lidocaine. In rats rendered hemiparkinsionian by lesioning the nigrostriatal pathway with 6OHDA, intrastriatal microinjection of flunarizine (50nmol/microl) significantly reduced apomorphine (0.2mg/kg, s.c.)-elicited turning behavior towards the non-lesioned side. These results suggest an antidopaminergic effect of flunarizine mediated by antagonistic action of post-synaptic striatal dopamine receptors. However, an action of the drug on sodium channels may not be ruled out. These studies offer additional supporting evidence for the induction or aggravation of extrapyramidal side-effects in patients receiving flunarizine.


Subject(s)
Calcium Channel Blockers/pharmacology , Dopamine/physiology , Flunarizine/pharmacology , Neostriatum/physiology , Synaptic Transmission/drug effects , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Apomorphine/pharmacology , Calcium Channels, L-Type/drug effects , Dopamine/metabolism , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Dopamine D2 Receptor Antagonists , Dose-Response Relationship, Drug , Haloperidol/pharmacology , Male , Microinjections , Neostriatum/drug effects , Neostriatum/metabolism , Nifedipine/pharmacology , Parkinson Disease, Secondary/psychology , Rats , Rats, Sprague-Dawley , Stereotyped Behavior/drug effects , Synapses/drug effects
20.
Am J Physiol Renal Physiol ; 280(1): F71-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11133516

ABSTRACT

The proposed feedback between angiotensin II AT(2) and AT(1) receptors prompted us to study AT(1) receptor expression in kidneys of male AT(2) receptor-gene disrupted mice (agtr2 -/y). In wild-type (agtr2 +/y) mice, AT(1) receptor binding and mRNA is abundant in glomeruli, and AT(1) receptor binding is also high in the inner stripe of the outer medulla. AT(2) receptors are scarce, primarily associated to cortical vascular structures. In agtr2 -/y mice, AT(1) receptor binding and mRNA were increased in the kidney glomeruli, and AT(1) receptor binding was higher in the rest of the cortex and outer stripe of the outer medulla, but not in its inner stripe, indicating different cellular regulation. Although AT(2) receptor expression is very low in male agtr 2 +/y mice, their gene disruption alters AT(1) receptor expression. AT(1) upregulation alone may explain the AT(2) gene-disrupted mice phenotype such as increased blood pressure, higher sensitivity to angiotensin II, and altered renal function. The indirect AT(1)/AT(2) receptor feedback could have clinical significance because AT(1) antagonists are widely used in medical practice.


Subject(s)
Kidney Glomerulus/metabolism , Receptors, Angiotensin/genetics , Receptors, Angiotensin/metabolism , Receptors, Angiotensin/physiology , Angiotensin II/pharmacology , Animals , Autoradiography , Blood Pressure/drug effects , Crosses, Genetic , Feedback , Genotype , Imidazoles/pharmacology , Kidney Cortex/blood supply , Kidney Cortex/metabolism , Kidney Medulla/metabolism , Losartan/pharmacology , Male , Mice , Mice, Inbred Strains , Mice, Knockout , Organ Specificity , Pyridines/pharmacology , RNA, Messenger/genetics , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Receptors, Angiotensin/deficiency , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...